Abstract
The use of polymeric nanoparticles as drug carriers is receiving an increasing amount of attention both in academia and industry. The development of suitable delivery systems for protein drugs with high molecular weights and short half-lives is of current interest. In addition, nanoparticles have a number of potential applications in drug and vaccine delivery as well as gene therapy applications. This article features a new production technology for nanoparticles comprised of multicomponent polymeric complexes that are candidates for delivery vehicles of biological molecules such as proteins and drugs. Materials science theory and practice provide the basis for the development of highly compacted structures that are insoluble in water and buffered media. Biocompatible and mostly natural polymers are fabricated into thermodynamically stable nanoparticles, in the absence of organic solvents, using two types of processing: batch and continuous. Careful choice of construction materials and the superposition of several interacting principles during their production allow for the customization of the physicochemical properties of the structures. Among the typical polymers used to assemble nanoparticles, different polysaccharides, natural amines and polyamines were investigated. The entrapped substances tested included proteins, antigens and small drug molecules. The size and charge of nanoparticles is considered to be of primary importance for application in biological systems. Detailed experiments in batch and continuous systems allowed time-dependent stoichiometric characterization of the production process and an understanding of fundamental assembly principles of such supramolecular structures. Continuous-flow production is shown to provide more consistent data in terms of product quality and consistency, with further possibilities of process development and commercialization. To control permeability, polydextran aldehyde, incorporated into the particle core, was used to enable physiologic cross-linking and long-term retention of substances that would otherwise rapidly leak out of the nanoparticles. Results of cross-linking experiments clearly demonstrated that the release rate could be substantially reduced, depending on the degree of cross-linking. For vaccine antigen delivery tests we measured an antibody production following subcutaneous and oral administration. The data indicated that only the cross-linked antigen was immunogenic when the oral route of administration was used. The data presented in this paper address primarily the utility of nanoparticulates for oral delivery of vaccine antigen. This novel technology is extensively discussed in contrast to other technologies, primarily water- and organic solvent-based. The usefulness is demonstrated using several examples, evaluating protein and small drug delivery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buckley A, Davidson JM, Kamerath CD, Wolt TB, Woodward SC (1985) Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 82:7340–7344
Vauthier-Holtzscherer C, Benabbou S, Spenlehauer G, Veillard M, Couvreur P (1991) Methodology for the preparation of ultra-dispersed polymer systems. STP Pharma Sci 2:109–116
Couvreur P, Roland M, Speiser P (1982) Biodegradable submicroscopic particles containing a biologically active substances and compositions containing them. US Patent 4,329,332
Cruz T, Gaspar R, Donato A, Lopes C (1997) Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production. Pharm Res 14:73–79
Gallo JM, Hung CT, Perrier DG (1984) Analysis of albumin microsphere preparation. Int J Pharm 22:63–74
Marty JJ, Openheim RC, Speiser P (1978) Nanoparticles. A new colloidal drug delivery system. Pharm Acta Helv 53:17–23
Ibrahim H, Gurny R, Bindschaedler C, Doelker E, Buri P (1990) A new technology for preparation of drug monodispersed systems for controlled release to the eye. Proc Int Symp Contr Rel Bioact Mat, Controlled Release Society 17:303–304
Fessi H, Puisieux F, Devissaguet J-P, Ammoury N, Benita S (1989) Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55:R1–R4
Alonso MJ (1998) Nanoparticulate drug carrier technology. In: Cohen S, H. Bernstein H (eds). Microparticulate Systems for the Delivery of Proteins and Vaccines. New York: Marcel Dekker, pp 203–242
Allen C, Eisenberg A, Maysinger D (1999a) Copolymer drug carriers: Conjugates, micelles and microspheres. STP Pharma Sci 9:139–151
Allen C, Maysinger D, Eisenberg A (1999b) Nano-engineering block copolymer aggregates for drug delivery. Coll Surf Interfaces 16 B:3–27
Nakache E, Poulain N, Candau F, Orecchioni A-M, Irache JM (2000) Biopolymer and polymer nanoparticles and their biomedical application. In: Nalwa HS (ed), Handbook of Nanostructured Materials and Nanotechnology. Vol 5: Organics, Polymers, and Biological Materials. New York: Academic Press, pp 577–635
Fitch RM (1997) Polymer Colloids: A Comprehensive Introduction. San Diego: Academic Press, pp 81–98
Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ (1997a) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polymer Sci 63:125–132
Calvo P, Remunan-Lopez, Vila-Jato JL, Alonso MH (1997b) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharmaceut Res 14:1431–1436
Prokop A (1999) Drug delivery system exhibiting permeability control. US patent pending; also PCT application WO9918934A1
Deacon S (1976) Assay of gentamicin in cerebrospinal fluid. J Clin Pathol 29:749–751
Prokop A, Holland CA, Kozlov E, Moore B, Tanner RD (2001) Water-based nanoparticulate polymeric system for protein delivery. Biotechnol Bioeng, 15:228–232.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein bicinchoninic acid [published erratum appears in Anal. Biochem 163:279 (1987)]. Anal Biochem 150:76–85
Fagnani R, Hagan MS, Bartholomew R (1990) Reduction of immunogenicity by covalent modification of murine and rabbit immunoglobulins with oxidized dextrans of low molecular weight. Cancer Res 50:3638–3645
Cheng H, Rudick MJ (1991) A membrane blotting method for following the time course of protein radioiodination background references using IODO-BEADS, Anal Biochem 198:191–193
Prokop A, Hunkeler DJ, DiMari S, Haralson MA, Wang TG (1998) Water soluble polymers for immunoisolation I: Complex coacervation and cytotoxicity. Advan Polymer Sci 136:1–52
Kabanov AV, Kabanov VA (1995) DNA complexes with polycations for the delivery of genetic material into cells. Bioconj Chem 6:7–20
Krone V, Magerstadt M, Walch A, Groner A, Hoffman D (1997) Pharmacological composition containing polyelectrolyte complexes in nanoparticulate form and at least one active agent. US Patent 5,700,459
Prokop A (1997) Micro-particulate and nano-particulate polymeric delivery system. US patent pending, 1997; also PCT application WO9918934A1
Janes KA, Calvo P, Alonso MJ (2001a) Polysaccharide colloidal particles as delivery systems for macromolecules. Advan Drug Delivery Revs 47:83–97
Bodmeier R, Chen H, Paeratakul O (1989) A novel approach to the oral delivery of micro-or nanoparticles. Pharm Res 6:413–417
Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P (1993) Development of a new drug carrier made from alginate. J Pharm Sci 82:912–917
Gribbonet EM, Hatley RHM, Gard T, Blair J, Kampinga J, Roser BJ (1996) Trehalose and novel hydrophobic sugar glasses in drug stabilization and delivery. In: Karsa DR, Stephenson RA (eds), Chemical Aspects of Drug Delivery Systems. Cambridge: The Royal Society of Chemistry, pp 138–145
Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL, Alonso MJ (1999) Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. S.T.P. Pharma Sci 9:429–436
Prokop A, Davidson JM, Dikov MM, Williams P (1999) Polymeric encapsulation system promoting angiogenesis. US patent pending; also PCT application WO0064954 A
Prokop A, Kozlov E, Newman GW, Newman MJ (2002) Water-based nanoparticulate polymeric system for protein delivery: Permeability control and vaccine application. Biotechnol Bioeng, accepted
Alonso MJ (1998) Nanoparticulate drug carrier technology. In: Cohen S, H. Bernstein H (eds), Microparticulate Systems for the Delivery of Proteins and Vaccines. New York: Marcel Dekker, pp 203–242
Decher G (1997) Fuzzy nanoassemblies: Towards layered polymeric multicomposites. Science 277:1232–1237
Anonymous (1995) NSF in a Changing World. The National Science Foundation’s Strategic Plan. NSF 95-24. http://www.nsf.gov/nsf/nsfpub/straplan/contents.htm
Anonymous (1999) Bioengineering Nanotechnology Initiative.
Williams DRM, Fredrickson GH (1992) Cylindrical micelles in rigid-flexible diblock copolymers, Macromol 25:3561–3568
Holyst R, Schick M (1992) Correlations in the rigid-flexible diblock copolymer systems. J Chem Phys 96:730–739
Jayaram B, DiCapua FM, Beveridge DL (1991) A theoretical study of polyelectrolyte effects in protein-DNA interactions: Monte Carlo free energy simulations on the ion atmosphere contribution to the thermodynamics of lambda repressor-operator complex formation. J Am Chem Soc 113:5211–5221
Webster L, Huglin MB, Robb ID (1997) Complex formation between polyelectrolytes in dilute aqueous solution. Polymer 38:1373–1380
Dautzenberg H, Hartmann J, Grunewald S, Brand F (1996) Stoichiometry and structure of polyelectrolyte complex particles in diluted solutions. Ber Bunsenges Phys Chem 100:1024–1032
Tsuchida E, Abe K (1988) Polyelectrolyte complexes. In: Wilson AD, Prosser HJ (eds), Developments in Ionic Polymers-2. London: Elsevier, pp 191–266
Chatterjee SK, Chhabra M, Rajabi FH, Farahani BV (1992) Thermodynamic studies of some copolymer-homopolymer-polyelectrolyte interactions. Polymer 33:3762–3766
Prokop A, Hunkeler DJ, DiMari S, Haralson MA, Wang TG (1998a) Water soluble polymers for immunoisolation I: Complex coacervation and cytotoxicity, Advan Polymer Sci 136:1–52
Prokop A, Hunkeler DJ, Wang TG (1998b) Water soluble polymers for immunoisolation II: Evaluation of multicomponent microencapsulation systems. Advan Polymer Sci 136:53–73
Wang T, Lacik I, Brissova M, Anilkumar AV, Prokop A, Hunkeler D, Green R, Shahrokhi K., Powers AC (1997) A new generation capsule and encapsulation system for immunoi-solation of pancreatic islets. Nature Biotechnol 15:358–362
Torza S, Mason SG (1970) Three-phase interactions in shear and electrical fields. J Coll Interface Sci 33:67–83
Pekarek KJ, Jacob JS, Mathiowitz E (1994) Double-walled polymer microspheres for controlled drug release. Nature 367:158–260
Lee JH, Lee HB, Andrade JD (1995) Blood compatibility of polyethylene oxide surfaces. Progr Polymer Sci 20:1043–1079
Singh M, Brioned M, Ott G, O’Hagan D (2000) Cationic microparticles: A potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97:811–816
Altmann KG (1993) Effect of cationization on anti-hapten antibody response in sheep and mice. Immunol Cell Biology 71:517–525
Schipper NG, Olsson S, Hoogstraate JA, de Boer AG, Varum KM, Artursson P (1997) Chitosans as absorption enhancers for poorly adsorbable drugs 2: Mechanism of absorption enhancement. Pharm Res 14:923–929
Jung T, Kamm W, Breitenbach A, Kaiserling E, Ziao JX, Kissel T (2000) Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake? Europ J Pharmac Biopharmaceut 50:147–160
Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Rel 73:255–267
Sussich F, Skopec C, Brady J, Cesaro A (2001) Reversible dehydration of trehalose and anhydrobiosis: from solution state to an exotic crystal? Carbohydrate Res 334:165–176
Shimomura M, Sawadaishi T (2001) Bottom-up strategy of materials fabrication: A new trend in nanotechnology of soft materials. Curr Opinion Coll Interf Sci 6:11–16
Singh M, Shirley B, Bajwa K, Samra E, Hora M, O’Hagan D (2001) Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. J Control Release 70:21–28
Peppas NA, Huang Y, Torres-Lugo M, Ward JH, Zhang J (2000) Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng 2:9–16
Wesselingh JA, Bollen AM (1997) Multicomponent diffusivities from the free volume theory. Chem Eng Res Des 75(A6):590–602
Kim C-J, Nujoma YE (1995) Drug release from an erodible drug-polyelectrolyte complex. Europ Polymer J 31:937–940
Remunan-Lopez C, Bodmeier R (1997) Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. J Control Rel 44:215–225
Yao K, Peng T, Xu M, Yuan C, Goosen MFA, Zhang Q, Ren L (1994) pH-dependent hydrolysis and drug release of chitosan/polyether interpenetrating polymer network hydrogel. Polymer Int. 34:213–219
Janes KA, Calvo P, Alonso MJ (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Advan Drug Delivery Revs 47:83–97
Kotov NA (1999) Layer-by-layer self-assembly: The contribution of hydrophobic interactions. NanoStruct Mat 12:789–796
Jaskari T, Vuorio M, Kontturi K, Manzanares JA, Hirvonen J (2001) Ion-exchange fibers and drugs: An equilibrium study. J Control Release 70:219–229
Ge S-J, Lee T-C (1997) Kinetic significance of the Schiff base reversion in the early-stage Maillard reaction of a phenylalanine-glucose aqueous model system. J Agric Food Chem 45:1619–1623
Chen S-S, Engel PC (1975) The equilibrium position of the reaction of bovine liver glutamate dehydrogenase with pyridoxal 5’-phosphate. Biochem J 147:351–358
Baldwin SP, Saltzman WM (1998) Materials for protein delivery in tissue engineering. Advan Drug Del Revs 33:71–86
Tobio M, Schwendeman SP, Guo Y, McIver J, Langer R, Alonso MJ (2000) Improved immunogenicity of a core-coated tetanus toxoid delivery system. Vaccine 18:618–622
Gomez-Orellana I, Paton DR (1998) Advances in the oral delivery of proteins. Exp Opinion Ther Patents 8:223–234
Matthews DM (1991) Protein Absorption. Wiley, New York
Woodley JF (1994) Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst 11:61–95
Jani P, Halbert GN, Landridgge J, Florence AT (1990) Nanoparticle uptake by the rat gastrointestinal mucose: Quantitation and particle size dependency. J Pharm Pharmacol 42:821–826
Damgge G, Aprahamian M, Marchais H, Benoit JP, Pinget M (1996) Intestinal absorption of PLGA microspheres in the gut. J Anat 189:491–501
Florence AT (1997) The oral absorption of micro-and nanoparticles: Neither exceptional nor unusual. Pharm Res 14:259–266
Puchel G, Montisci M-J, Dembri A, Durrer C, Duchene D (1997) Mucoadhesion of colloidal particulate system in the gastro-intestinal tract,. Europ J Pharm Biopharmaceut 44:25–31
Lehr C-M (1994) Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract, Crit Rev Drug Carrier Syst 11:119–160
Hunt G, Pearney P, Kellaway I (1987) Mucoadhesive polymers in drug delivery systems, In: Johnson P. Lloyd-Jones JG (eds), Drug Delivery Systems. Fundamentals and Techniques. Ellis Horwood, Chichester, pp 180–199
Capron I, Yvon M, Muller G (1996) In vitro gastric stability of carrageenan. Food Hydrocol 10:239–244
Lavelle EC, Charif S, Thomas NW, Holland J, Davis SS (1995) The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv Drug Del Revs 18:5–22
De Campos AM, Sanchez A, Alonso MJ (2001) Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to ocular surface. Application to cyclosporin A. Int J Pharm 224:159–168
Kaneda Y, Yamamoto Y, Kamada H, Tsunoda S, Tsutsumi Y, Hirano T, Mayumi Y (1998) Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic acid anhydride copolymer on solid tumors in mice. Cancer Res 58:290–295
Pierce GF, Tarpley JE, Janagihara D, Mustoe TA, Fox GM, Thomason A (1992) Platelet-derived growth factor (BB homodimer), transforming growth factor-beta, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Amer J Pathol 140:1375–1388
Puolakkainen PA, Twardzik DR, Rauchalis JE, Pankey SC, Reed MJ, Gombotz WR (1995) The enhancement in wound healing by transforming growth factor β1 (TGFβ1) depends on the topical delivery system. J Surg Res 58:321–329
Couvreur P, Dubernet C, Puisieux F (1995) Controlled drug-delivery with nanoparticles. Current possibilities and future trends. Europ J Pharm Biopharm 41:2–13
Capello J, Crissman JW, Crissman M, Ferrari FA, Textor G, Wallis O, Whitledge JR, Zhou X, Burman D, Aukerman L, Stedronsky ER (1998) In-situ self-assembling polymer gel systems for administration, delivery, and release of drugs. J Control Release 53:105–117
Leon EJ, Verma N, Zhang S, Lauffenburger DA, Kamm RD (1998) Mechanical properties of a self-assembling oligopeptide matrix. J Biomat Sci Polymer Edn 9:297–312
Katayose S, Kataoka K (1997) Water-soluble polyanion complex associates of DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer. Bioconjugate Chem 8:702–707
Aynie IC, Vauthier C, Fattal E, Foulquier M, Couvreur P (1998) Alginate nanoparticles as a novel carrier for antisense oligonucleotide. In: Diederichs JE, Muler R (eds), Future Strategies of Drug Delivery with Particulate Systems. Stuttgart: Medipharm Scientific Publisher, pp 5–10
Tokumitsu H, Ichikawa H, Fukumori Y (1999) Chitosan-gadopenteic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: Preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res 16:1839–1835
Jung T, Breitenbach A, Kissel T (2000) Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) facilitate the preparation of small negatively charged biode-gradable nanospheres for protein delivery. J Control Rel 67:157–169
Gaur U, Sahoo SK, De TK, Ghosh P, Maitra A, Ghosh PK (2000) Biodistribution of fluo-resceinated dextran using novel nanoparticles evading reticuloendothelial system. Int J Pharm 202:1–10
Weber C, Coester C, Kreuter J, Langer K (2000) Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 194:91–102
Zhang X, Burt HM, VonHoff D, Dexter D, Mangold G, Degen D, Oktaba AM, Hunter WL (1997) An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol 40:81–86
Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka A, Sakurai Y, Ikano T (1998) Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 50:79–92
Cleland JL, Daugherty A, Mrsny R (2001) Emerging protein delivery methods. Curr Opinion Biotechnol 12:212–219
Breimer DD (1998) Future challenges for drug delivery research. Advan Drug Del Revs 33:265–268
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Prokop, A., Kozlov, E., Carlesso, G., Davidson, J.M. (2002). Hydrogel-Based Colloidal Polymeric System for Protein and Drug Delivery: Physical and Chemical Characterization, Permeability Control and Applications. In: Filled Elastomers Drug Delivery Systems. Advances in Polymer Science, vol 160. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-45362-8_3
Download citation
DOI: https://doi.org/10.1007/3-540-45362-8_3
Received:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-43052-0
Online ISBN: 978-3-540-45362-8
eBook Packages: Springer Book Archive